8C61ICD-11 MMS 2026-01
Congenital myasthenic syndromes
Description
Congenital myasthenic syndrome (CMS) is a heterogeneous group of genetically determined diseases. There are four well-defined categories: Congenital myasthenic syndrome with presynaptic defect, Synaptic basal lamina-associated CMS, Congenital myasthenia with postsynaptic defect, CMS with glycosylation deficiency, and the remaining category is that of unidentified CMS.
Index terms
- Congenital myasthenic syndromes
- congenital and developmental myasthenia
- congenital myasthenia
Show allHide
- developmental myasthenia
- Congenital endplate acetylcholine receptor deficiency
- congenital defects in acetylcholine receptor subunits
- Congenital slow channel syndrome
- Congenital myasthenia with presynaptic defect
- Congenital myasthenia with postsynaptic defect
- post synaptic congenital myasthenic syndrome
- Congenital myasthenic syndrome with glycosylation deficiency
- Congenital myasthenia with synaptic basal lamina defects
- Congenital myasthenia with congenital endplate acetylcholinesterase deficiency
- Familial infantile myasthenia
- Limb-girdle myasthenia, familial
- Limb-girdle myasthenia, nonfamilial
- myasthenic myopathy, nonfamilial
- Certain specified congenital or developmental myasthenia
- inherited neuromuscular disorders
- Congenital amyotonia
- Oppenheim disease
- amyotonia congenita
Exclusions from above levels
05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium19– Certain conditions originating in the perinatal period
Show allHide
22– Injury, poisoning or certain other consequences of external causes
Sibling codes
Foundation entity
Congenital myasthenic syndromes – http://id.who.int/icd/entity/1515367530
Part of: 08: Diseases of the nervous system